According to the study, 53.4% of participants receiving NF were free of cancer at three months and 45.5% of patients continued to be cancer-free for at least 12 months.

Media contact: Will Sansom, sansom@uthscsa.edu, (210) 567-2579 SAN ANTONIO (March 25, 2021) — Insomnia and obstructive sleep apnea have increased dramatically among active-duty military members over a 14-year period, 2005 through 2019. Insomnia increased 45-fold and sleep apnea went up more than 30-fold, according to a study led by The University of Texas Health Science […]

Media contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 19, 2021) — In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment. Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a […]

Media contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 11, 2021) — Treatment with convalescent plasma was associated with significant survival benefit in patients with blood cancer who were hospitalized with COVID-19. The new data analysis was released Feb. 5 by the COVID-19 and Cancer Consortium (CCC19). The Mays Cancer Center, home to UT […]

UT Health San Antonio was one of only four sites in Texas to receive the first doses of Pfizer’s COVID-19 vaccine Monday. The university received nearly 6,000 doses of the vaccine, which gained emergency use authorization Dec. 10 from the U.S. Food and Drug Administration.